Viewing Study NCT05429905

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:21 AM
Ignite Modification Date: 2026-05-19 @ 6:04 AM
Study NCT ID: NCT05429905
Status: RECRUITING
Last Update Posted: 2023-03-09
First Post: 2021-12-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia
Sponsor: KK Women's and Children's Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoblastic Leukemia View
None Lymphoblastic Leukemia, Acute, Childhood View
None Lymphoblastic Leukemia in Children View
None Lymphoblastic Leukemia, Acute Adult View
None CAR View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CAR T-cell therapy View
None B-ALL View
None Relapsed/ Refractory View